Thanks for posting this here in the Knowledge Base, Lisa, very helpful. Apart from our registered members we have many unregistered `guests` who also visit this forum. Being an open public forum all the information we share here is available to anyone who finds us in an internet search.
Note that this compassionate use protocol of Daclatasvir and Sofosbuvir (w. or w.o Ribavirin) is specifically aimed at those people with advanced Hep C liver disease who cannot afford to wait for treatment with Dac/Sof to be FDA approved and then become available in Europe, and this is a quote from the clinical trials link you`ve posted...
"The primary objective of this program is to provide Daclatasvir in combination with Sofosbuvir with or without ribavirin to subjects with chronic hepatitis C who are at a high risk of liver decompensation or death within 12 months if left untreated and who have no available therapeutic options."
I`m making this a `sticky` post. ~ Jill
Tig said
Jun 8, 2014
Hi Lisa,
We were talking about this recently and I'm glad you found it too. It's so important to share these opportunities when they're found. My thought goes out to Zlickster and hope he's able to take advantage of one when it comes his way. I'll send him a note just in case he missed it. Thanks for pointing it out Lisa!
I don't know how many from this forum are from Europe and need compassionate use, but it is now available in the Netherlands, and other European countries:
Thanks for posting this here in the Knowledge Base, Lisa, very helpful. Apart from our registered members we have many unregistered `guests` who also visit this forum. Being an open public forum all the information we share here is available to anyone who finds us in an internet search.
Note that this compassionate use protocol of Daclatasvir and Sofosbuvir (w. or w.o Ribavirin) is specifically aimed at those people with advanced Hep C liver disease who cannot afford to wait for treatment with Dac/Sof to be FDA approved and then become available in Europe, and this is a quote from the clinical trials link you`ve posted...
"The primary objective of this program is to provide Daclatasvir in combination with Sofosbuvir with or without ribavirin to subjects with chronic hepatitis C who are at a high risk of liver decompensation or death within 12 months if left untreated and who have no available therapeutic options."
I`m making this a `sticky` post. ~ Jill
Hi Lisa,
We were talking about this recently and I'm glad you found it too. It's so important to share these opportunities when they're found. My thought goes out to Zlickster and hope he's able to take advantage of one when it comes his way. I'll send him a note just in case he missed it. Thanks for pointing it out Lisa!
Tig
http://hepcfriends.activeboard.com/t57673346/solvadi-and-daclatasvir-side-effects/
I don't know how many from this forum are from Europe and need compassionate use, but it is now available in the Netherlands, and other European countries:
http://clinicaltrials.gov/ct2/show/NCT02097966